Search Results

There are 31631 results for: content related to: The regulatory role of the tetrapeptide A c SDKP in skin and hair physiology and the prevention of ageing effects in these tissues – a potential cosmetic role

  1. You have free access to this content
    Antifibrotic peptide N-acetyl-Ser-Asp-Lys-Pro (Ac-SDKP): Opportunities for angiotensin-converting enzyme inhibitor design

    Clinical and Experimental Pharmacology and Physiology

    Volume 40, Issue 8, August 2013, Pages: 535–541, Ross G Douglas, Mario R Ehlers and Edward D Sturrock

    Version of Record online : 29 JUL 2013, DOI: 10.1111/1440-1681.12062

  2. You have free access to this content
    Prolyl oligopeptidase induces angiogenesis both in vitro and in vivo in a novel regulatory manner

    British Journal of Pharmacology

    Volume 163, Issue 8, August 2011, Pages: 1666–1678, TT Myöhänen, J Tenorio-Laranga, B Jokinen, R Vázquez-Sánchez, MJ Moreno-Baylach, JA García-Horsman and PT Männistö

    Version of Record online : 25 JUL 2011, DOI: 10.1111/j.1476-5381.2010.01146.x

  3. On-line solid-phase extraction LC-MS/MS for the determination of Ac-SDKP peptide in human plasma from hemodialysis patients

    Biomedical Chromatography

    Volume 26, Issue 2, February 2012, Pages: 137–141, Koichi Inoue, Ayaka Ikemura, Yoshinari Tsuruta, Kaname Tsutsumiuchi, Tomoaki Hino and Hisao Oka

    Version of Record online : 19 APR 2011, DOI: 10.1002/bmc.1636

  4. You have full text access to this OnlineOpen article
    Effects of N-acetyl-seryl-asparyl-lysyl-proline on blood pressure, renal damage, and mortality in systemic lupus erythematosus

    Physiological Reports

    Volume 5, Issue 2, January 2017, Pablo Nakagawa, Juan X. Masjoan-Juncos, Heba Basha, Branislava Janic, Morel E. Worou, Tang-Dong Liao, Cesar A. Romero, Edward L. Peterson and Oscar A. Carretero

    Version of Record online : 26 JAN 2017, DOI: 10.14814/phy2.13084

  5. Establishment and clinical application of a highly sensitive enzyme immunoassay for determination of N-acetyl-seryl-aspartyl-lysyl-proline

    Journal of Peptide Science

    Volume 18, Issue 4, April 2012, Pages: 276–281, Yosuke Suzuki, Hiroki Itoh, Fumihiko Katagiri, Fuminori Sato, Kanako Kawasaki, Yuhki Sato, Hiromitsu Mimata and Masaharu Takeyama

    Version of Record online : 7 MAR 2012, DOI: 10.1002/psc.2400

  6. Sphingosine 1-Phosphate (S1P) Induces S1P2 Receptor-Dependent Tonic Contraction in Murine Iliac Lymph Vessels


    Volume 20, Issue 1, January 2013, Pages: 1–16, Koichiro Kimizuka, Yoshiko Kawai, Daisuke Maejima, Kumiko Ajima, Maki Kaidoh and Toshio Ohhashi

    Version of Record online : 9 JAN 2013, DOI: 10.1111/micc.12001

  7. Synthesis and application of sodium 2-acrylamido-2-methylpropane sulphonate/N-vinylcaprolactam/divinyl benzene as a high-performance viscosifier in water-based drilling fluid

    Journal of Applied Polymer Science

    Volume 133, Issue 43, November 15, 2016, Binqiang Xie, Xiaodong Liu, Huiqiang Wang and Lihui Zheng

    Version of Record online : 15 JUL 2016, DOI: 10.1002/app.44140

  8. Synthesis and biological evaluation of analogues of the tetrapeptide N-acetyl-Ser-Asp-Lys-Pro (AcSDKP), an inhibitor of primitive haematopoietic cell proliferation

    Journal of Peptide Science

    Volume 7, Issue 5, May 2001, Pages: 284–293, Josiane Thierry, Catherine Grillon, Sandrine Gaudron, Pierre Potier, Andrew Riches and Joanna Wdzieczak-Bakala

    Version of Record online : 1 MAY 2001, DOI: 10.1002/psc.322

  9. The tetrapeptide acserasplyspro (seraspenide), a hematopoietic inhibitor, may reduce the in vitro toxicity of 3′-Azido-3′-deoxythymidine to human hematopoietic progenitors


    Volume 11, Issue 5, 1993, Pages: 455–464, Catherine Grillon, Dominique Bonnet, Jean-Yves Mary, Maryse Lenfant, Albert Najman and Dr. Martine Guigon

    Version of Record online : 1 JAN 1996, DOI: 10.1002/stem.5530110513

  10. The tetrapeptide acetyl-serine-aspartyl-lysine-proline improves skin flap survival and accelerates wound healing

    Wound Repair and Regeneration

    Volume 14, Issue 3, May–June 2006, Pages: 306–312, Yves Fromes, Jian-Miao Liu, Milica Kovacevic, Jérôme Bignon and Joanna Wdzieczak-Bakala

    Version of Record online : 28 JUN 2006, DOI: 10.1111/j.1743-6109.2006.00125.x

  11. Amelioration of Chemotherapy-Induced Toxicity by Cotreatment with AcSDKP, a Tetrapeptide Inhibitor of Hematopoietic Stem Cell Proliferation

    Annals of the New York Academy of Sciences


    Version of Record online : 17 DEC 2006, DOI: 10.1111/j.1749-6632.1991.tb17230.x

  12. N-acetyl-seryl-aspartyl-lysyl-proline Mediates the Anti-fibrotic Properties of Captopril in Unilateral Ureteric Obstructed BALB/C Mice


    Accepted manuscript online: 11 JAN 2017, Gary CW Chan, Hao Jia Wu, Kam Wa Chan, Stella Yiu, Ailis Zou, Xiao Ru Huang, Hui Yao Lan, Kar Neng Lai and Sydney CW Tang

    DOI: 10.1111/nep.13000

  13. Src and phospho-FAK kinases are activated by allopregnanolone promoting Schwann cell motility, morphology and myelination

    Journal of Neurochemistry

    Volume 141, Issue 2, April 2017, Pages: 165–178, Simona Melfi, Maria Magdalena Montt Guevara, Veronica Bonalume, Massimiliano Ruscica, Alessandra Colciago, Tommaso Simoncini and Valerio Magnaghi

    Version of Record online : 10 FEB 2017, DOI: 10.1111/jnc.13951

  14. You have free access to this content
    Inhibitory Action of the Peptide AcSDKP on the Proliferative State of Hematopoietic Stem Cells in the Presence of Captopril but not Lisinopril


    Volume 15, Issue 6, November 1997, Pages: 455–460, Dr. J. E. Chisi, J. Wdzieczak-Bakala and A. C. Riches

    Version of Record online : 1 NOV 1997, DOI: 10.1002/stem.150455

  15. Angiotensin I-Converting Enzyme And Metabolism Of The Haematological Peptide N-Acetyl-Seryl-Aspartyl-Lysyl-Proline

    Clinical and Experimental Pharmacology and Physiology

    Volume 28, Issue 12, December 2001, Pages: 1066–1069, Michel Azizi, Christophe Junot, Eric Ezan and Joël Ménard

    Version of Record online : 6 JAN 2002, DOI: 10.1046/j.1440-1681.2001.03560.x

  16. The molecular specificity of action of the tetrapeptide acetyl-n-ser-asp-lys-pro (AcSDKP) in the control of hematopoietic stem cell proliferation


    Volume 11, Issue 5, 1993, Pages: 422–427, Dr. Simon Robinson, Maryse Lenfant, Joanna Wdzieczak-Bakala and Andrew Riches

    Version of Record online : 1 JAN 1996, DOI: 10.1002/stem.5530110509

  17. You have free access to this content
    In Vitro Effect of Acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) Analogs Resistant to Angiotensin I-Converting Enzyme on Hematopoietic Stem Cell and Progenitor Cell Proliferation


    Volume 17, Issue 2, March 1999, Pages: 100–106, Sandrine Gaudron, Dr. Catherine Grillon, Josiane Thierry, Andrew Riches, Pieter K. Wierenga and Joanna Wdzieczak-Bakala

    Version of Record online : 1 MAR 1999, DOI: 10.1002/stem.170100

  18. The antiproliferative activity of the tetrapeptide Acetyl-N-SerAspLysPro, an inhibitor of haematopoietic stem cell proliferation, is not mediated by a thymosin β4-like effect on actin assembly

    Cell Proliferation

    Volume 29, Issue 8, August 1996, Pages: 437–446, N. Cheviron, C. Grillon, M.-F. Carlier and J. Wdzieczak-Bakala

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1365-2184.1996.tb00986.x

  19. AcSDKP serum concentrations vary during chemotherapy in patients with acute myeloid leukaemia

    British Journal of Haematology

    Volume 89, Issue 4, April 1995, Pages: 917–920, Eric Liozon, Leonid Volkov, Lydie Comte, Franck Trimoreau, Philippe Pradelles, Dominique Bordessoule, Emilia Frindel and Vincent Praloran

    Version of Record online : 12 MAR 2008, DOI: 10.1111/j.1365-2141.1995.tb08438.x

  20. The mechanism of action of the tetrapeptide Acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) in the control of haematopoietic stem cell proliferation

    Cell Proliferation

    Volume 25, Issue 6, November 1992, Pages: 623–632, S. Robinson, M. Lenfant, J. Wdzieczak-Bakala, J. Melville and A. Riches

    Version of Record online : 1 MAY 2008, DOI: 10.1111/j.1365-2184.1992.tb01464.x